Abiraterone acetate (CB7630), a pregnenolone analog, is an orally administered small molecule that irreversibly inhibits a rate-limiting enzyme in androgen biosysnthesis, CYP17, and blocks the ...

Although not a cure, abiraterone can help stop prostate cancer spreading to other parts of the body. NHS England said it would review the drug's use for more men next year. In England and Northern ...

This Prostate Cancer Awareness Month, we’re celebrating over 10 years since abiraterone was first recommended by NICE in England as a treatment for advanced prostate cancer. We share the story of the ...

The drug's safety and efficacy were evaluated in combination with abiraterone and ADT against abiraterone and ADT alongside placebo. The Truqap combination showed a promising early trend towards ...

AstraZeneca (NASDAQ:AZN) reported positive results from a Phase 3 study of its drug Truqap in the treatment ... showed that Truqap in combination with abiraterone and androgen deprivation therapy ...

Our research is helping men with prostate cancer live longer. We discovered the drug abiraterone and are developing new ways of treating and diagnosing prostate cancer - including genetic testing and ...

(RTTNews) - British drug maker AstraZeneca Plc (AZN.L, AZN) announced Monday positive high-level results from CAPItello-281 Phase III trial of Truqap (capivasertib) in combination with abiraterone ...

Future Oncol. 2010;6(5):665-679. Three Phase I studies by O'Donnell and colleagues have reported the pharmacodynamic activity of abiraterone acetate, which was originally developed as an oral ...

The phase 3 CAPItello-281 trial has been comparing the efficacy and safety of the drug in combination with abiraterone and androgen deprivation therapy (ADT) against abiraterone and ADT plus placebo ...